Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Butler

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
AIDS (London, England)|November 30, 2020
Pharmacokinetics and safety of maraviroc in neonatesJulia C Rosebush, Brookie M Best, Ellen G Chadwick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2017
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical TrialPatricia M Flynn, Taha E Taha, Mae Cababasay, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2021
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum ComponentPatricia M Flynn, Taha E Taha, Mae Cababasay, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
AIDS (London, England)|November 30, 2020
Pharmacokinetics and safety of maraviroc in neonatesJulia C Rosebush, Brookie M Best, Ellen G Chadwick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2017
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical TrialPatricia M Flynn, Taha E Taha, Mae Cababasay, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2021
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum ComponentPatricia M Flynn, Taha E Taha, Mae Cababasay, et al.
Pageof 4